Search results
Fauci’s memoir reveals clashes with Trump, other private moments
Washington Post· 16 hours agoThe call from President Donald Trump arrived at 9:30 Sunday morning, Nov. 1, 2020 — two days before...
KRX Growth Companies With High Insider Ownership And At Least 26% Earnings Growth
Simply Wall St. via Yahoo Finance· 1 day agoThe South Korean market has shown promising growth, rising 1.1% over the past week and achieving a...
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
Zacks via Yahoo Finance· 4 days agoAbbVie (ABBV) signs an exclusive global licensing deal with the Chinese company FutureGen to develop...
Tacalyx extends seed funding round to raise over €14m
Pharmaceutical Technology via Yahoo Finance· 7 days agoCancer-focused biotech Tacalyx has extended its seed financing round to raise over €14m ($15.03m)....
Shoring up blood vessels may offer new approach for treating autoimmune rheumatic diseases
Medical Xpress· 1 day agoA study from physician-scientists at the Hospital for Special Surgery (HSS) points to a potential...
Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including...
Lodi News-Sentinel· 1 day agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs ...
Third Rock’s Marea ropes in $190M to pioneer ‘the next frontier’ of cardiometabolic medicines
FierceBiotech· 14 hours agoMarea Therapeutics has emerged with $190 million, a mid-stage clinical program and a plan to harness...
Avidity Biosciences, Inc. Announces Pricing of Public Offering of Common Stock
The Mammoth Times· 5 days agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs ...
No Detriment to RA Starting MTX a Month After PCV13
Medscape· 2 days agoPneumococcal vaccination administered 1 month prior to starting methotrexate (MTX) in patients with rheumatoid arthritis (RA) allows a significantly...
Lingering cholesterol can keep heart risk high. Marea Therapeutics has $190M to target it.
BioPharma Dive via Yahoo Finance· 18 hours agoWeiss’ new startup, Marea Therapeutics, officially joined the hunt Tuesday, launching with $190...